Opiate-induced hypernociception and chemokine receptors

Neuropharmacology

Volumn 58, Issue 1, 2010, Pages 35-37

  White, Fletcher ^a   Wilson, Natalie ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Opiate; Opiate induced hyperalgesia

Indexed keywords

CHEMOKINE RECEPTOR; GLUTAMATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; MU OPIATE RECEPTOR; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHRONIC PAIN; CONSTIPATION; DRUG TOLERANCE; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERALGESIA; INTERNALIZATION; NAUSEA; NERVE CELL PLASTICITY; NEUROMODULATION; NOCICEPTION; NONHUMAN; OPIATE INDUCED TACTILE HYPERNOCICEPTION; OPIOID INDUCED EMESIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RESPIRATION DEPRESSION; SEDATION; SIDE EFFECT; SIGNAL TRANSDUCTION;

ANIMALS; CHEMOKINES; HUMANS; HYPERALGESIA; MORPHINE; NARCOTICS; PAIN; PAIN THRESHOLD; RECEPTORS, CHEMOKINE; RECEPTORS, OPIOID;

EID: 71549149656     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.07.012     Document Type: Article

References (34)

1. Angst M.S., Koppert W., Pahl I., Clark D.J., and Schmelz M. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 106 (2003) 49-57
2. Arner S., Rawal N., and Gustafsson L.L. Clinical experience of long-term treatment with epidural and intrathecal opioids - a nationwide survey. Acta Anaesthesiol. Scand. 32 (1988) 253-259
3. Bhangoo, S., Ripsch, M.S., Buchanan, D., Miller, R.J., White, F.A. Increased chemokine signaling in a rodent model of HIV-associated painful neuropathy. Mol. Pain, in press.
4. Bhangoo S.K., Ren D., Miller R.J., Chan D.M., Ripsch M.S., Weiss C., McGinnis C., and White F.A. CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. Brain Behav. Immun. 21 (2007) 581-591
5. Celerier E., Rivat C., Jun Y., Laulin J.P., Larcher A., Reynier P., and Simonnet G. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92 (2000) 465-472
6. Chen Y., Geis C., and Sommer C. Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway. J. Neurosci. 28 (2008) 5836-5845
7. Colpaert F.C. Mechanisms of opioid-induced pain and antinociceptive tolerance: signal transduction. Pain 95 (2002) 287-288
8. Donahoe R.M., and Vlahov D. Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J. Neuroimmunol. 83 (1998) 77-87
9. Guignard B., Bossard A.E., Coste C., Sessler D.I., Lebrault C., Alfonsi P., Fletcher D., and Chauvin M. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 93 (2000) 409-417
10. Gutstein H.B. The effects of pain on opioid tolerance: how do we resolve the controversy?. Pharmacol. Rev. 48 (1996) 403-407 (discussion 409-411)
11. Ji R.R., Gereau R.W.T., Malcangio M., and Strichartz G.R. MAP kinase and pain. Brain Res. Rev. 60 (2009) 135-148
12. Laulin J.P., Celerier E., Larcher A., Le Moal M., and Simonnet G. Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 89 (1999) 631-636
13. Laulin J.P., Larcher A., Celerier E., Le Moal M., and Simonnet G. Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time. Eur. J. Neurosci. 10 (1998) 782-785
14. Li M., and Ransohoff R.M. Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog. Neurobiol. 84 (2008) 116-131
15. Luginbuhl M., Gerber A., Schnider T.W., Petersen-Felix S., Arendt-Nielsen L., and Curatolo M. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth. Analg. 96 (2003) 726-732 (table of contents)
16. Lynch J.L., and Banks W.A. Opiate modulation of IL-1alpha, IL-2, and TNF-alpha transport across the blood-brain barrier. Brain Behav. Immun. 22 (2008) 1096-1102
17. Ma W., Zheng W.-H., Powell K., Jhamandas K., and Quirion R. Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur. J. Neurosci. 14 (2001) 1091-1104
18. Mao J., Price D.D., and Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62 (1995) 259-274
19. Miller R.J., Banisadr G., and Bhattacharyya B.J. CXCR4 signaling in the regulation of stem cell migration and development. J. Neuroimmunol (2008)
20. Narita M., Ioka M., Suzuki M., and Suzuki T. Effect of repeated administration of morphine on the activity of extracellular signal regulated kinase in the mouse brain. Neurosci. Lett. 324 (2002) 97-100
21. Ossipov M.H., Lai J., King T., Vanderah T.W., Malan Jr. T.P., Hruby V.J., and Porreca F. Antinociceptive and nociceptive actions of opioids. J. Neurobiol. 61 (2004) 126-148
22. Patel J.P., Sengupta R., Bardi G., Khan M.Z., Mullen-Przeworski A., and Meucci O. Modulation of neuronal CXCR4 by the micro-opioid agonist DAMGO. J. Neurovirol. 12 (2006) 492-500
23. Schonemeier B., Kolodziej A., Schulz S., Jacobs S., Hoellt V., and Stumm R. Regional and cellular localization of the CXCl12/SDF-1 chemokine receptor CXCR7 in the developing and adult rat brain. J. Comp. Neurol. 510 (2008) 207-220
24. Singla A., Stojanovic M.P., Chen L., and Mao J. A differential diagnosis of hyperalgesia, toxicity, and withdrawal from intrathecal morphine infusion. Anesth. Analg. 105 (2007) 1816-1819 (table of contents)
25. Steele A.D., Henderson E.E., and Rogers T.J. Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology 309 (2003) 99-107
26. Szabo I., Chen X.H., Xin L., Adler M.W., Howard O.M., Oppenheim J.J., and Rogers T.J. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 10276-10281
27. Tashiro K., Tada H., Heilker R., Shirozu M., Nakano T., and Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 261 (1993) 600-603
28. Tran P.B., Banisadr G., Ren D., Chenn A., and Miller R.J. Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain. J. Comp. Neurol. 500 (2007) 1007-1033
29. Vanderah T.W., Gardell L.R., Burgess S.E., Ibrahim M., Dogrul A., Zhong C.M., Zhang E.T., Malan Jr. T.P., Ossipov M.H., Lai J., and Porreca F. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J. Neurosci. 20 (2000) 7074-7079
30. Vanderah T.W., Suenaga N.M., Ossipov M.H., Malan Jr. T.P., Lai J., and Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J. Neurosci. 21 (2001) 279-286
31. White F.A., Jung H., and Miller R.J. Chemokines and the pathophysiology of neuropathic pain. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 20151-20158
32. Wilson, N.M., Jung, H., Ripsch, M.S., Miller, R.J., White, F.A., 2008. Opioid-induced tactile hyperalgesia is attenuated by the CXCR4 antagonist, AMD3100, 38th Annual Meeting Society for Neuroscience, Washington, DC.
33. Woolf C.J. Intrathecal high dose morphine produces hyperalgesia in the rat. Brain Res. 209 (1981) 491-495
34. Zhang N., Rogers T.J., Caterina M., and Oppenheim J.J. Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize {micro}-opioid receptors on dorsal root ganglia neurons. J. Immunol. 173 (2004) 594-599